Shuichi Nakatsuru
Comptroller/Controller/Auditor en Immunas Pharma, Inc. .
Fortuna: 631 976 $ al 30/04/2024
Perfil
Shuichi Nakatsuru is currently working as an Auditor at Immunas Pharma, Inc. since 2008.
Prior to this, he worked as the Director, VP & Head-Business Development at OncoTherapy Science, Inc. from 2007 to 2008.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
31/03/2023 | 5 850 000 ( 2.62% ) | 631 976 $ | 30/04/2024 |
Cargos activos de Shuichi Nakatsuru
Empresas | Cargo | Inicio |
---|---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Comptroller/Controller/Auditor | 01/06/2008 |
Antiguos cargos conocidos de Shuichi Nakatsuru.
Empresas | Cargo | Fin |
---|---|---|
ONCOTHERAPY SCIENCE, INC. | Presidente | 01/04/2003 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |
- Bolsa de valores
- Insiders
- Shuichi Nakatsuru